The FDA has approved Abbott’s AndroGel 1.62%, a testosterone gel that restores levels of the hormone in hypogonadal men with half the volume of gel at the starting dose than delivered in AndroGel 1%.
The newly approved formulation contains 40.5 mg of testosterone in two pump presses, compared with the 1% gel’s 50 mg in four pump presses.
With different dosage and administration instructions, the two gels are not interchangeable.
From the June 01, 2011 Issue of Renal and Urology News
Next post in Hypogonadism
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
Want to read more?
Please login or register first to view this content.